Ozonized Hydrogel and Chlorhexidine Gel for Peri‐Implant Mucositis: A 24‐Month Randomized Controlled Trial
Oral Diseases · 2026-05 · 32 (5) · 1412-1431
DOI: 10.1111/odi.70120 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oral Diseases, online erschienen am 13.10.2025. Verfasst von Andrea Scribante und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University o…. Hauptthemen laut MEDLINE: Chlorhexidine, Anti-Infective Agents, Local, Stomatitis, Dental Implants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This randomized controlled trial evaluated the 24‐month effectiveness of a nonsurgical intervention for peri‐implant mucositis, comparing a 15% ozonated sunflower oil hydrogel with a 1% chlorhexidine gel.
Methods
Thirty patients with 360 peri‐implant mucositis sites were treated in a split‐mouth design, receiving both therapies in randomly assigned quadrants. Clinical parameters—probing pocket depth (PPD), plaque index (PI), bleeding on probing (BoP), bleeding score (BS), suppuration index (SI), and marginal mucosal condition (MMC)—were recorded at baseline and nine follow‐ups. Marginal bone level (MBL) was measured radiographically at baseline, 6, 15, and 24 months. Recurrence was defined as the reappearance of BoP, SI, or MMC after resolution. Data were analyzed with the Friedman test and Dunn's post hoc.
Results
Both treatments produced significant improvements. The ozonated hydrogel achieved faster and greater reductions in BoP, BS, and SI, with significant differences at 6 and 24 months. MBL remained stable in both groups, with no progression to peri‐implantitis. No adverse events occurred, and compliance was maintained.
Conclusions
The ozonated sunflower hydrogel provided superior anti‐inflammatory effects over chlorhexidine, particularly in reducing bleeding and suppuration, while preserving bone stability. Its safety, efficacy, and acceptability support its use as an adjunct in peri‐implant mucositis maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
- Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
- Maxilo-Facial Surgery and Dental Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Tissue Regeneration and Repair Group, Biomaterials and Tissue Engineering, Faculty of Health Sciences, UCAM-Universidad Catòlica San Antonio de Murcia, Murcia, Spain.
- Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
ORCID-Profile: Maurizio Pascadopoli, Matteo Pellegrini, Andrea Butera
Zitieren
APA
Scribante, A., Pascadopoli, M., Pellegrini, M., Lupi, M. S., Martínez, C. P., & Butera, A. (2026). Ozonized Hydrogel and Chlorhexidine Gel for Peri‐Implant Mucositis: A 24‐Month Randomized Controlled Trial. Oral Diseases, 32(5), 1412-1431. https://doi.org/10.1111/odi.70120
Vancouver
Scribante A, Pascadopoli M, Pellegrini M, Lupi MS, Martínez CP, Butera A. Ozonized Hydrogel and Chlorhexidine Gel for Peri‐Implant Mucositis: A 24‐Month Randomized Controlled Trial. Oral Diseases. 2026;32(5):1412-1431. doi:10.1111/odi.70120
BibTeX
@article{Scribante2026,
author = {Scribante, Andrea and Pascadopoli, Maurizio and Pellegrini, Matteo and Lupi, Marco Saturnino and Martínez, Carlos Pérez-Albacete and Butera, Andrea},
title = {Ozonized Hydrogel and Chlorhexidine Gel for Peri‐Implant Mucositis: A 24‐Month Randomized Controlled Trial},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {5},
pages = {1412--1431},
doi = {10.1111/odi.70120}
}
EUVIMED